Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Swiss Re (SRENH.S)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (CHF)	Price Target (CHF)	Rating
2022-03-30	88.84	75.00	Sell
2022-06-16	73.74	69.00	Sell
2022-09-15	82.66	71.00	Sell
2022-10-31	74.40	68.00	Sell
2023-01-12	93.24	77.00	Sell
2023-02-21	96.50	82.00	Sell
2023-11-06	99.10	85.00	Sell
2023-12-06	98.76	90.00	Sell
2024-01-17	97.68	87.00	Sell
2024-02-19	100.15	91.00	Sell
2024-06-03	113.55	101.00	Sell
2024-10-18	116.80	106.00	Sell
2024-11-11	122.55	136.00	Buy
2024-11-18	125.00	150.00	Buy
2025-02-28	144.30	155.00	Buy
2025-06-24	136.30	150.00	Buy

Disclosures

UBS has acted as manager/co-manager in the underwriting or placement of securities of this company/entity or one of its affiliates within the past 12 months.
Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
UBS expects to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.
This company/entity is, or within the past 12 months has been, a client of UBS Securities LLC, and non-investment banking securities-related services are being, or have been, provided.
This company/entity is, or within the past 12 months has been, a client of UBS Securities LLC, and non-securities services are being, or have been, provided.
Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
An employee of UBS is an officer, director, or advisory board member of this company.
UBS beneficially owned 1% or more of a class of this company`s common equity securities as of last month`s end (or the prior month`s end if this report is dated less than 10 days after the most recent month`s end).
UBS holds a long or short position of 0.5% or more of the listed shares of this company.
UBS Fund Management (Switzerland) AG beneficially owns more than 5% of the total issued share capital of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.